Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Misoprostol + tranexamic acid versus misoprostol for blood loss reduction during abdominal myomectomy
PACTR202508845388900Phase 0Not yet recruiting
- Sponsor
- Fatima Inusa Anga
- Start
- Sep 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 0, randomised, open-label trial of misoprostol and tranexamic acid in Fibromyoma (LM), sponsored by Fatima Inusa Anga. Planned start Sep 2025; status: not yet recruiting.
02
Drugs
misoprostoltranexamic acid
03
Conditions
Fibromyoma (LM)
Beyond the preview
Go deeper on PACTR202508845388900.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202508845388900.